(Q44678067)

5 December 2017

Hemorrhagic cystitis after allogeneic bone marrow transplantation in children: clinical characteristics and outcome (English)

1 reference

5 December 2017

1 reference

3

Heslop HE

1 reference

5 December 2017

Hale GA

1

1 reference

5 December 2017

Rochester RJ

2

1 reference

5 December 2017

Krance RA

4

1 reference

5 December 2017

Gingrich JR

5

1 reference

5 December 2017

Benaim E

6

1 reference

5 December 2017

Horwitz EM

7

1 reference

5 December 2017

Cunningham JM

8

1 reference

5 December 2017

Tong X

9

1 reference

5 December 2017

Srivastava DK

10

1 reference

5 December 2017

Leung WH

11

1 reference

5 December 2017

Woodard P

12

1 reference

5 December 2017

Bowman LC

13

1 reference

5 December 2017

Handgretinger R

14

1 reference

5 December 2017

1 November 2003

1 reference

Biology of Blood and Marrow Transplantation

5 December 2017

1 reference

5 December 2017

9

1 reference

5 December 2017

11

1 reference

5 December 2017

698-705

1 reference

Risk factors for severe hemorrhagic cystitis following BMT

5 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900269-6

7 January 2021

Haemorrhagic cystitis: incidence and risk factors in a transplant population using hyperhydration

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900269-6

7 January 2021

Human polyomavirus BK (BKV) load and haemorrhagic cystitis in bone marrow transplantation patients

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900269-6

7 January 2021

Quantification of polyoma BK viruria in hemorrhagic cystitis complicating bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900269-6

7 January 2021

Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900269-6

7 January 2021

Outcomes of transplantation with matched-sibling and unrelated-donor bone marrow in children with leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900269-6

7 January 2021

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900269-6

7 January 2021

Response of steroid-resistant graft-versus-host disease to lymphoblast antibody CBL1.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900269-6

7 January 2021

The Analysis of Failure Times in the Presence of Competing Risks

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900269-6

7 January 2021

Cyclophosphamide cystitis—Identification of acrolein as the causative agent

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900269-6

7 January 2021

Urinary excretion and pharmacokinetics of acrolein and its parent drug cyclophosphamide in bone marrow transplant patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900269-6

7 January 2021

Adenovirus infection after pediatric bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900269-6

7 January 2021

Relevance of bone marrow cell dose on allogeneic transplantation outcomes for patients with acute myeloid leukemia in first complete remission: results of a European survey

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900269-6

7 January 2021

Polyomavirus Viruria in Bone Marrow Transplant Recipients: Lack of Correlation with Clinical Symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900269-6

7 January 2021

Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900269-6

7 January 2021

Late-onset hemorrhagic cystitis after hematopoietic stem cell transplantation in children

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900269-6

7 January 2021

Hemorrhagic cystitis due to adenovirus infection following bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900269-6

7 January 2021

Cyclic recovery of adenovirus in a stem cell transplant recipient: an inverse association with graft-versus-host disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900269-6

7 January 2021

A randomized trial comparing prednisone with antithymocyte globulin/prednisone as an initial systemic therapy for moderately severe acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900269-6

7 January 2021

Immunosuppression with limited toxicity: the characteristics of nucleoside analogs and anti-lymphocyte antibodies used in non-myeloablative hematopoietic cell transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900269-6

7 January 2021

Suspected delayed immune recovery against cytomegalovirus after reduced-intensity stem cell transplantation using anti-thymocyte globulin

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900269-6

7 January 2021

Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO).

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900269-6

7 January 2021

Cytomegalovirus-induced hemorrhagic cystitis following bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900269-6

7 January 2021

Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900269-6

7 January 2021

BK virus as cause of haemorrhagic cystitis after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900269-6

7 January 2021

Sequential vidarabine infusion in the treatment of polyoma virus-associated acute haemorrhagic cystitis late after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900269-6

7 January 2021

Encouraging results in the treatment of haemorrhagic cystitis with estrogen - report of 10 cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900269-6

7 January 2021

Cidofovir treatment of human polyomavirus-associated acute haemorrhagic cystitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900269-6

7 January 2021

Intravesical rhGM-CSF for the treatment of late onset hemorrhagic cystitis after bone marrow transplant

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900269-6

7 January 2021

Factor XIII replacement in stem-cell transplant recipients with severe hemorrhagic cystitis: a report of four cases

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900269-6

7 January 2021

Cystectomy for severe hemorrhagic cystitis in allogeneic stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900269-6

7 January 2021

Megadose transplantation of purified peripheral blood CD34(+) progenitor cells from HLA-mismatched parental donors in children

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900269-6

7 January 2021

10.1016/S1083-8791(03)00269-6

Identifiers

DOI

1 reference

5 December 2017

1 reference